Targeted Oncology
Targeted Oncology
Targeted Oncology

The Genetic Landscape of AML

Richard M. Stone, MD
Published Online:1:10 PM, Wed April 12, 2017

Richard M. Stone, MD, chief of staff, program director, adult leukemia, institute physician, professor of medicine, Harvard Medical School, Dana-Farber Cancer Institute, discusses what is currently understood regarding the genetic landscape in acute myeloid leukemia (AML).
Publications